[Determination of troponin in the diagnosis of acute myocardial infarction in practice: clinico-economic analysis].
The authors first made a clinicoeconomic analysis of benefits from the introduction a rapid test for cardiac troponins in Russian routine clinical practice for the diagnosis of acute myocardial infarction. The economic gains associated with the reduced number of both optional hospitalizations and unwarranted refusals of hospitalization were calculated. The probable economic benefit of the improved diagnosis of myocardial infarction after total introduction of the test for troponins was 324.86 rbl. per patient. The importance of a clinicoeconomic analysis is shown to solve the problem of introducing the diagnostic tests into medical practice.
Ostrovskiĭ
O V
OV
Brezgina
M F
MF
Zaĭtsev
V G
VG
D015415:Biomarkers / Q000097:blood; D001774:Blood Chemical Analysis / Q000191:economics; D003362:Cost-Benefit Analysis; D004562:Electrocardiography / Q000191:economics; D006760:Hospitalization / Q000191:economics; D006801:Humans; D018803:Models, Economic; D009203:Myocardial Infarction / Q000097:blood / Q000175:diagnosis* / Q000191:economics; D014336:Troponin / Q000097:blood*
D015415:Biomarkers; D014336:Troponin